These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 28244178)

  • 1. Evaluation of an optimized [
    Caminiti SP; Alongi P; Majno L; Volontè MA; Cerami C; Gianolli L; Comi G; Perani D
    Eur J Neurol; 2017 May; 24(5):687-e26. PubMed ID: 28244178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A disease-specific metabolic brain network associated with corticobasal degeneration.
    Niethammer M; Tang CC; Feigin A; Allen PJ; Heinen L; Hellwig S; Amtage F; Hanspal E; Vonsattel JP; Poston KL; Meyer PT; Leenders KL; Eidelberg D
    Brain; 2014 Nov; 137(Pt 11):3036-46. PubMed ID: 25208922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDG PET in the differential diagnosis of degenerative parkinsonian disorders: usefulness of voxel-based analysis in clinical practice.
    Arnone A; Allocca M; Di Dato R; Puccini G; Laghai I; Rubino F; Nerattini M; Ramat S; Lombardi G; Ferrari C; Bessi V; Sorbi S; De Cristofaro MT; Polito C; Berti V
    Neurol Sci; 2022 Sep; 43(9):5333-5341. PubMed ID: 35697965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET Molecular Imaging in Atypical Parkinsonism.
    Xu Z; Arbizu J; Pavese N
    Int Rev Neurobiol; 2018; 142():3-36. PubMed ID: 30409257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The utility of FDG-PET in the differential diagnosis of Parkinsonism.
    Brajkovic L; Kostic V; Sobic-Saranovic D; Stefanova E; Jecmenica-Lukic M; Jesic A; Stojiljkovic M; Odalovic S; Gallivanone F; Castiglioni I; Radovic B; Trajkovic G; Artiko V
    Neurol Res; 2017 Aug; 39(8):675-684. PubMed ID: 28378615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential diagnosis of parkinsonian syndromes using F-18 fluorodeoxyglucose positron emission tomography.
    Tripathi M; Dhawan V; Peng S; Kushwaha S; Batla A; Jaimini A; D'Souza MM; Sharma R; Saw S; Mondal A
    Neuroradiology; 2013 Mar; 55(4):483-92. PubMed ID: 23314836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 18F-FDG PET Is an Early Predictor of Overall Survival in Suspected Atypical Parkinsonism.
    Hellwig S; Frings L; Amtage F; Buchert R; Spehl TS; Rijntjes M; Tüscher O; Weiller C; Weber WA; Vach W; Meyer PT
    J Nucl Med; 2015 Oct; 56(10):1541-6. PubMed ID: 26229141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different metabolic patterns analysis of Parkinsonism on the 18F-FDG PET.
    Juh R; Kim J; Moon D; Choe B; Suh T
    Eur J Radiol; 2004 Sep; 51(3):223-33. PubMed ID: 15294329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [¹⁸F]FDG-PET is superior to [¹²³I]IBZM-SPECT for the differential diagnosis of parkinsonism.
    Hellwig S; Amtage F; Kreft A; Buchert R; Winz OH; Vach W; Spehl TS; Rijntjes M; Hellwig B; Weiller C; Winkler C; Weber WA; Tüscher O; Meyer PT
    Neurology; 2012 Sep; 79(13):1314-22. PubMed ID: 22914831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Voxel-based comparison of regional cerebral glucose metabolism between PSP and corticobasal degeneration.
    Hosaka K; Ishii K; Sakamoto S; Mori T; Sasaki M; Hirono N; Mori E
    J Neurol Sci; 2002 Jul; 199(1-2):67-71. PubMed ID: 12084445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain glucose metabolism in Lewy body dementia: implications for diagnostic criteria.
    Caminiti SP; Sala A; Iaccarino L; Beretta L; Pilotto A; Gianolli L; Iannaccone S; Magnani G; Padovani A; Ferini-Strambi L; Perani D
    Alzheimers Res Ther; 2019 Feb; 11(1):20. PubMed ID: 30797240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of
    Presotto L; Ballarini T; Caminiti SP; Bettinardi V; Gianolli L; Perani D
    Neuroinformatics; 2017 Apr; 15(2):151-163. PubMed ID: 28063108
    [No Abstract]   [Full Text] [Related]  

  • 13. Validation of an optimized SPM procedure for FDG-PET in dementia diagnosis in a clinical setting.
    Perani D; Della Rosa PA; Cerami C; Gallivanone F; Fallanca F; Vanoli EG; Panzacchi A; Nobili F; Pappatà S; Marcone A; Garibotto V; Castiglioni I; Magnani G; Cappa SF; Gianolli L;
    Neuroimage Clin; 2014; 6():445-54. PubMed ID: 25389519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SPECT Molecular Imaging in Atypical Parkinsonism.
    Brumberg J; Isaias IU
    Int Rev Neurobiol; 2018; 142():37-65. PubMed ID: 30409259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcranial sonography and [18F]fluorodeoxyglucose positron emission tomography for the differential diagnosis of parkinsonism: a head-to-head comparison.
    Hellwig S; Reinhard M; Amtage F; Guschlbauer B; Buchert R; Tüscher O; Weiller C; Niesen WD; Meyer PT
    Eur J Neurol; 2014 Jun; 21(6):860-6. PubMed ID: 24602186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral glucose metabolism in corticobasal degeneration comparison with progressive supranuclear palsy using statistical mapping analysis.
    Juh R; Pae CU; Kim TS; Lee CU; Choe B; Suh T
    Neurosci Lett; 2005 Jul 22-29; 383(1-2):22-7. PubMed ID: 15936506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Single-Subject Brain Metabolic Patterns in the Early Differential Diagnosis of Primary Progressive Aphasias and in Prediction of Progression to Dementia.
    Cerami C; Dodich A; Greco L; Iannaccone S; Magnani G; Marcone A; Pelagallo E; Santangelo R; Cappa SF; Perani D
    J Alzheimers Dis; 2017; 55(1):183-197. PubMed ID: 27662315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Syndrome-specific patterns of regional cerebral glucose metabolism in posterior cortical atrophy in comparison to dementia with Lewy bodies and Alzheimer's disease--a [F-18]-FDG pet study.
    Spehl TS; Hellwig S; Amtage F; Weiller C; Bormann T; Weber WA; Hüll M; Meyer PT; Frings L
    J Neuroimaging; 2015; 25(2):281-288. PubMed ID: 24593796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Typical cerebral metabolic patterns in neurodegenerative brain diseases.
    Teune LK; Bartels AL; de Jong BM; Willemsen AT; Eshuis SA; de Vries JJ; van Oostrom JC; Leenders KL
    Mov Disord; 2010 Oct; 25(14):2395-404. PubMed ID: 20669302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDG PET in the differential diagnosis of parkinsonian disorders.
    Eckert T; Barnes A; Dhawan V; Frucht S; Gordon MF; Feigin AS; Eidelberg D
    Neuroimage; 2005 Jul; 26(3):912-21. PubMed ID: 15955501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.